These informal reports show great promise in the off-label use of GLP-1RAs
Cocaine Only limited clinical evidence is available for GLP-1RAs in cocaine misuse: a small ( N = 13) proof-of-concept trial across 2 days showed that exenatide compared with placebo did not reduce the number of self-administered cocaine infusions 115 , while a case series of 3 individuals with cocaine-use disorder highlighted the feasibility and safety of using the same drug over 6 weeks, although no efficacy measures were reported 116
If you do drink, do so with food, slowly, and in moderation and never on an empty stomach
By selectively inhibiting NNMT , 5-Amino-1MQ can reduce the methylation of nicotinamide, leading to increased intracellular NAD availability and enhanced metabolic activity
In one study, for example, dysesthesia appeared in nearly 21 percent of retatrutide users versus less than 1 percent on placebo
Doctors usually start patients on a low dose, increasing it every four weeks to minimize side effects